| MLEC | Moolec Science SA | 0.01 | -99.98% |
| LSB | LakeShore Biopharma Co Ltd | 0.02 | -99.94% |
| ENVB | Enveric Biosciences Inc | 0.08 | -99.79% |
| KPRX | Kiora Pharmaceuticals Inc | 0.14 | -99.62% |
| JAGX | Jaguar Health Inc | 0.30 | -99.19% |
| LITS | Lite Strategy Inc | 0.31 | -99.17% |
| AFMD | Affimed N.V. | 0.53 | -98.60% |
| FTRE | FORTE SOFTWARE INC | 0.54 | -98.58% |
| BDRX | Biodexa Pharmaceuticals Plc | 0.58 | -98.47% |
| ENSC | Ensysce Biosciences Inc | 0.61 | -98.38% |
| CLSD | Clearside Biomedical, Inc. Common Stock | 0.64 | -98.29% |
| ONCT | Oncternal Therapeutics Inc | 0.72 | -98.09% |
| GOSS | Gossamer Bio Inc | 0.98 | -97.41% |
| CELU | Celularity Inc - Class A | 1.00 | -97.35% |
| XLO | Xilio Therapeutics Inc | 1.05 | -97.22% |
| IMRN | Immuron Ltd | 1.11 | -97.06% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | 1.12 | -97.03% |
| HRTX | Heron Therapeutics Inc | 1.14 | -96.97% |
| AGEN | Agenus Inc | 1.15 | -96.96% |
| FBIOP | Fortress Biotech Inc | 1.25 | -96.69% |
| SCNI | Scinai Immunotherapeutics Ltd | 1.31 | -96.51% |
| KPTI | Karyopharm Therapeutics Inc | 1.36 | -96.38% |
| MDXG | Mimedx Group Inc | 1.38 | -96.34% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | 1.39 | -96.30% |
| CSBR | Champions Oncology Inc | 1.40 | -96.29% |
| FBIO | Fortress Biotech Inc | 1.46 | -96.13% |
| RVNC | Revance Therapeutics Inc | 1.48 | -96.07% |
| AVIR | Atea Pharmaceuticals Inc | 1.55 | -95.88% |
| BOLT | Bolt Biotherapeutics Inc | 1.57 | -95.84% |
| PBYI | Puma Biotechnology Inc | 1.61 | -95.74% |
| CRMD | CorMedix Inc | 1.66 | -95.60% |
| MGNX | Macrogenics Inc | 1.68 | -95.53% |
| NEUP | Neuphoria Therapeutics Inc | 1.70 | -95.49% |
| GLPG | Galapagos NV | 1.74 | -95.38% |
| VNDA | Vanda Pharmaceuticals Inc | 1.78 | -95.27% |
| VERU | Veru Inc | 1.79 | -95.26% |
| SVA | Sinovac Biotech Ltd | 1.83 | -95.14% |
| NERV | Minerva Neurosciences Inc | 1.87 | -95.04% |
| RIGL | Rigel Pharmaceuticals | 1.88 | -95.01% |
| ONCO | Onconetix Inc | 1.95 | -94.83% |
| THTX | Theratechnologies Inc | 1.98 | -94.74% |
| PTN | Palatin Technologies Inc | 2.03 | -94.62% |
| HRMY | Harmony Biosciences Holdings Inc | 2.03 | -94.60% |
| BDTX | Black Diamond Therapeutics Inc | 2.11 | -94.40% |
| XBIO | Xenetic Biosciences Inc | 2.21 | -94.13% |
| RADX | Radiopharm Theranostics Ltd | 2.22 | -94.12% |
| PLX | Protalix BioTherapeutics Inc | 2.26 | -94.01% |
| MGX | Metagenomi Inc | 2.29 | -93.92% |
| HCWB | HCW Biologics Inc | 2.30 | -93.90% |
| SPRC | SciSparc Ltd | 2.33 | -93.81% |
| NAGE | Niagen Bioscience Inc | 2.36 | -93.75% |
| GNFT | GENFIT S.A. American Depositary Shares | 2.44 | -93.54% |
| CLGN | CollPlant Biotechnologies Ltd New | 2.49 | -93.39% |
| SAVA | Cassava Sciences Inc. | 2.54 | -93.27% |
| PHAR | Pharming Group N.V. | 2.61 | -93.07% |
| FULC | Fulcrum Therapeutics Inc | 2.66 | -92.95% |
| VRCA | Verrica Pharmaceuticals Inc | 2.66 | -92.93% |
| APVO | Aptevo Therapeutics Inc | 2.70 | -92.83% |
| CUE | Cue Biopharma Inc | 2.71 | -92.82% |
| SPRO | Spero Therapeutics Inc | 2.81 | -92.56% |
| REVB | Revelation Biosciences Inc | 2.88 | -92.35% |
| SABS | SAB Biotherapeutics Inc | 2.96 | -92.15% |
| HYFT | MindWalk Holdings Corp | 2.98 | -92.10% |
| SXTP | 60 Degrees Pharmaceuticals Inc | 3.01 | -92.01% |
| NVAX | Novavax Inc | 3.02 | -91.97% |
| MNKD | Mannkind Corp | 3.04 | -91.93% |
| CDXS | Codexis Inc | 3.07 | -91.85% |
| ICCC | Immucell Corp | 3.10 | -91.79% |
| BMRN | Biomarin Pharmaceutical Inc | 3.12 | -91.71% |
| CRIS | Curis Inc | 3.13 | -91.70% |
| AAPG | Ascentage Pharma Group International | 3.23 | -91.43% |
| ACAD | Acadia Pharmaceuticals Inc | 3.31 | -91.21% |
| PTHS | Channel Therapeutics Corporation | 3.32 | -91.19% |
| BCAB | BioAtla Inc | 3.35 | -91.10% |
| JAZZ | Jazz Pharmaceuticals plc | 3.36 | -91.09% |
| RARE | Ultragenyx Pharmaceutical Inc | 3.44 | -90.88% |
| QTTB | Q32 Bio Inc | 3.49 | -90.75% |
| CTXR | Citius Pharmaceuticals Inc | 3.49 | -90.75% |
| APLM | Apollomics Inc - Class A | 3.51 | -90.68% |
| ARDX | Ardelyx Inc | 3.56 | -90.54% |
| IMCR | Immunocore Holdings plc | 3.57 | -90.53% |
| CGEN | Compugen Ltd | 3.59 | -90.47% |
| ADMA | Adma Biologics Inc | 3.60 | -90.45% |
| INCY | Incyte Corp | 3.63 | -90.38% |
| SLDB | Solid Biosciences Inc | 3.65 | -90.33% |
| IPSC | Century Therapeutics Inc | 3.72 | -90.14% |
| PHAT | Phathom Pharmaceuticals Inc | 3.73 | -90.10% |
| BRNS | Barinthus Biotherapeutics Plc. | 3.80 | -89.92% |
| VALN | Valneva SE | 3.82 | -89.86% |
| INVA | Innoviva Inc | 3.88 | -89.70% |
| EVGN | Evogene Ltd | 3.89 | -89.69% |
| RGNX | Regenxbio Inc | 3.91 | -89.63% |
| BGMS | Bio Green Med Solution Inc | 3.98 | -89.44% |
| DTIL | Precision Biosciences Inc | 3.99 | -89.41% |
| TLX | Telix Pharmaceuticals Ltd | 4.02 | -89.34% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | 4.08 | -89.17% |
| ATRA | Atara Biotherapeutics Inc | 4.10 | -89.11% |
| ARCT | Arcturus Therapeutics Holdings Inc | 4.12 | -89.08% |
| GERN | Geron Corp | 4.12 | -89.06% |
| GMAB | Genmab | 4.14 | -89.01% |
| REGN | Regeneron Pharmaceuticals Inc | 4.41 | -88.30% |
| EVAX | Evaxion Biotech A/S | 4.54 | -87.95% |
| YMAB | Y-Mabs Therapeutics Inc | 4.57 | -87.88% |
| ZLAB | Zai Lab Ltd | 4.58 | -87.86% |
| LEGN | Legend Biotech Corp | 4.61 | -87.77% |
| TRAW | Traws Pharma Inc | 4.70 | -87.54% |
| ABUS | Arbutus Biopharma Corp | 4.71 | -87.49% |
| STRO | Sutro Biopharma Inc | 4.73 | -87.46% |
| TARS | Tarsus Pharmaceuticals Inc | 4.79 | -87.30% |
| GYRE | Gyre Therapeutics Inc | 4.90 | -87.00% |
| CLLS | Cellectis | 5.00 | -86.75% |
| ACHV | Achieve Life Sciences Inc | 5.09 | -86.50% |
| BCYC | Bicycle Therapeutics Plc | 5.16 | -86.31% |
| CAI | Caris Life Sciences Inc - Class A | 5.19 | -86.23% |
| ONC | BeiGene Ltd | 5.20 | -86.20% |
| ELAB | PMGC Holdings Inc | 5.26 | -86.04% |
| EXEL | Exelixis Inc | 5.29 | -85.97% |
| FDMT | 4D Molecular Therapeutics Inc | 5.31 | -85.91% |
| HALO | Halozyme Therapeutics Inc | 5.40 | -85.67% |
| CHRS | Coherus Biosciences Inc | 5.46 | -85.51% |
| ADCT | Adc Therapeutics SA | 5.46 | -85.51% |
| ENTA | Enanta Pharmaceuticals Inc | 5.54 | -85.30% |
| ZVRA | Zevra Therapeutics Inc | 5.60 | -85.14% |
| VCEL | Vericel Corp | 5.99 | -84.11% |
| IVVD | Invivyd Inc | 6.01 | -84.05% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | 6.02 | -84.04% |
| SCPH | scPharmaceuticals Inc | 6.10 | -83.83% |
| OSRH | Bellevue Life Sciences Acquisition Corp | 6.14 | -83.71% |
| TECH | Bio-Techne Corp | 6.22 | -83.50% |
| RNA | Atrium Therapeutics Inc | 6.23 | -83.47% |
| SEER | Seer Inc - Class A | 6.40 | -83.02% |
| VYGR | Voyager Therapeutics Inc | 6.41 | -82.99% |
| CPRX | Catalyst Pharmaceuticals Inc | 6.42 | -82.97% |
| ARQT | Arcutis Biotherapeutics Inc | 6.46 | -82.86% |
| ARVN | Arvinas Inc | 6.48 | -82.81% |
| AUPH | Aurinia Pharmaceuticals Inc | 6.61 | -82.46% |
| KROS | Keros Therapeutics Inc | 6.71 | -82.20% |
| FENC | Fennec Pharmaceuticals Inc | 6.83 | -81.88% |
| CYCN | Cyclerion Therapeutics Inc | 6.84 | -81.85% |
| IOVA | Iovance Biotherapeutics Inc | 6.85 | -81.83% |
| ZNTL | Zentalis Pharmaceuticals Inc | 7.13 | -81.08% |
| TCRX | Tscan Therapeutics Inc | 7.14 | -81.07% |
| OBIO | Orchestra BioMed Holdings Inc | 7.15 | -81.03% |
| DYAI | Dyadic International Inc DE | 7.27 | -80.71% |
| ANAB | AnaptysBio Inc | 7.29 | -80.66% |
| MRKR | Marker Therapeutics Inc | 7.38 | -80.42% |
| PTCT | PTC Therapeutics Inc | 7.41 | -80.34% |
| VSTM | Verastem Inc | 7.53 | -80.02% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | 7.58 | -79.90% |
| ALGS | Aligos Therapeutics Inc | 7.62 | -79.78% |
| ASMB | Assembly Biosciences Inc | 7.63 | -79.76% |
| TBPH | Theravance Biopharma Inc | 7.64 | -79.73% |
| NTBL | Notable Labs Inc Ord | 7.65 | -79.70% |
| PSTV | Plus Therapeutics Inc | 7.68 | -79.62% |
| SNDX | Syndax Pharmaceuticals Inc | 7.90 | -79.04% |
| ARTV | Artiva Biotherapeutics Inc | 8.11 | -78.48% |
| PYXS | Pyxis Oncology Inc | 8.14 | -78.40% |
| IMMP | Immutep Ltd | 8.16 | -78.35% |
| TVTX | Travere Therapeutics Inc | 8.28 | -78.03% |
| MRNA | Moderna Inc | 8.49 | -77.48% |
| TGTX | TG Therapeutics Inc | 8.57 | -77.26% |
| BNTX | BioNTech SE | 8.65 | -77.05% |
| FHTX | Foghorn Therapeutics Inc | 8.88 | -76.44% |
| XNCR | Xencor Inc | 8.93 | -76.31% |
| PRTA | Prothena Corporation plc | 9.06 | -75.96% |
| VRTX | Vertex Pharmaceuticals Inc | 9.08 | -75.91% |
| GOVX | Geovax Labs Inc | 9.09 | -75.88% |
| SPRY | ARS Pharmaceuticals Inc | 9.10 | -75.86% |
| ALNY | Alnylam Pharmaceuticals Inc | 9.21 | -75.56% |
| CORT | Corcept Therapeutics Inc | 9.30 | -75.33% |
| LPCN | Lipocine Inc | 9.39 | -75.09% |
| NXTC | Nextcure Inc | 9.52 | -74.74% |
| ACET | Adicet Bio Inc | 9.72 | -74.21% |
| SNGX | Soligenix Inc | 9.78 | -74.05% |
| URGN | UroGen Pharma Ltd | 10.20 | -72.94% |
| HOWL | Werewolf Therapeutics Inc | 10.21 | -72.91% |
| ICU | SeaStar Medical Holding Corp | 10.33 | -72.59% |
| IKT | Inhibikase Therapeutics Inc | 10.39 | -72.43% |
| MDGL | Madrigal Pharmaceuticals Inc | 10.69 | -71.64% |
| XOMA | XOMA Corp | 10.78 | -71.40% |
| MIRM | Mirum Pharmaceuticals Inc | 10.87 | -71.16% |
| TNXP | Tonix Pharmaceuticals Holding Corp | 11.03 | -70.74% |
| ARGX | Argen X SE | 11.04 | -70.71% |
| CTNM | Contineum Therapeutics Inc - Class A | 11.15 | -70.42% |
| BCDA | BioCardia Inc | 11.35 | -69.89% |
| IDYA | Ideaya Biosciences Inc | 11.49 | -69.52% |
| NUVB | Nuvation Bio Inc - Class A | 11.56 | -69.33% |
| LENZ | LENZ Therapeutics Inc | 11.62 | -69.17% |
| ATHE | Alterity Therapeutics Ltd | 11.74 | -68.85% |
| CCCC | C4 Therapeutics Inc | 11.75 | -68.83% |
| PALI | Palisade Bio Inc | 11.78 | -68.75% |
| IONS | Ionis Pharmaceuticals Inc | 11.80 | -68.69% |
| PRQR | ProQR Therapeutics N.V | 12.05 | -68.03% |
| BLRX | Bioline Rx Ltd | 12.05 | -68.03% |
| XBIT | XBiotech Inc | 12.23 | -67.55% |
| MGTX | MeiraGTx Holdings plc | 12.37 | -67.18% |
| KURA | Kura Oncology Inc | 12.39 | -67.13% |
| SLGL | Sol-Gel Technologies Ltd | 12.45 | -66.97% |
| ACOG | Alpha Cognition Inc | 12.45 | -66.97% |
| KALV | KalVista Pharmaceuticals Inc | 12.46 | -66.94% |
| MDWD | MediWound Ltd | 12.64 | -66.46% |
| RPRX | Royalty Pharma plc - Class A | 12.73 | -66.23% |
| ALEC | Alector Inc | 13.02 | -65.46% |
| RCUS | Arcus Biosciences Inc | 13.50 | -64.18% |
| ANL | Adlai Nortye Ltd | 13.52 | -64.12% |
| OABI | OmniAb Inc | 13.53 | -64.10% |
| XCUR | Exicure Inc | 13.61 | -63.89% |
| EDIT | Editas Medicine Inc | 13.68 | -63.71% |
| CRVO | CervoMed Inc | 13.78 | -63.44% |
| LXRX | Lexicon Pharmaceuticals Inc | 13.84 | -63.28% |
| COYA | Coya Therapeutics Inc | 14.24 | -62.22% |
| CVAC | CureVac N.V. | 14.83 | -60.65% |
| APLT | Applied Therapeutics Inc | 14.86 | -60.57% |
| GDTC | CytoMed Therapeutics Ltd | 16.08 | -57.34% |
| AXSM | Axsome Therapeutics Inc | 16.96 | -55.00% |
| ASND | Ascendis Pharma A/S | 17.02 | -54.84% |
| LGND | Ligand Pharmaceuticals Inc - Class B | 17.22 | -54.31% |
| WVE | Wave Life Sciences Ltd | 17.27 | -54.18% |
| CANF | Can-Fite Biopharma Ltd | 17.72 | -52.99% |
| ARWR | Arrowhead Pharmaceuticals Inc | 17.89 | -52.54% |
| IMNN | Imunon Inc | 17.94 | -52.40% |
| PRLD | Prelude Therapeutics Inc | 18.67 | -50.47% |
| SEPN | Septerna Inc | 18.84 | -50.02% |
| IPHA | Innate Pharma | 19.08 | -49.38% |
| LGVN | Longeveron Inc - Class A | 20.07 | -46.75% |
| EQ | Equillium Inc | 20.22 | -46.35% |
| LIXT | Lixte Biotechnology Holdings Inc | 20.35 | -46.01% |
| CRBU | Caribou Biosciences Inc | 20.45 | -45.74% |
| BEAM | Beam Therapeutics Inc | 20.53 | -45.53% |
| NRXS | Neuraxis Inc | 21.43 | -43.14% |
| NTRB | Nutriband Inc | 21.76 | -42.27% |
| KRYS | Krystal Biotech Inc | 21.81 | -42.14% |
| ABCL | AbCellera Biologics Inc | 22.09 | -41.39% |
| ABEO | Abeona Therapeutics Inc | 22.25 | -40.97% |
| BBIO | BridgeBio Pharma Inc | 22.38 | -40.62% |
| LCTX | Lineage Cell Therapeutics Inc | 22.43 | -40.49% |
| ZYME | Zymeworks BC Inc | 22.55 | -40.17% |
| CTMX | CytomX Therapeutics Inc | 23.09 | -38.74% |
| PLUR | Pluri Inc | 23.20 | -38.45% |
| APM | Aptorum Group Ltd - Class A | 23.35 | -38.05% |
| UNCY | Unicycive Therapeutics Inc | 23.75 | -36.99% |
| KALA | Kala Bio Inc | 23.75 | -36.99% |
| ADTX | Aditxt Inc | 23.84 | -36.75% |
| VIR | Vir Biotechnology Inc | 24.57 | -34.81% |
| NBP | NovaBridge Biosciences. | 25.39 | -32.64% |
| NRIX | Nurix Therapeutics Inc | 25.59 | -32.11% |
| AGIO | Agios Pharmaceuticals Inc | 25.77 | -31.63% |
| CGEM | Cullinan Oncology Inc | 25.86 | -31.39% |
| IGC | IGC Pharma Inc | 26.14 | -30.65% |
| AIM | AIM ImmunoTech Inc. | 26.38 | -30.01% |
| VIVS | VivoSim Labs Inc | 26.70 | -29.16% |
| SLS | SELLAS Life Sciences Group Inc | 26.90 | -28.63% |
| VRDN | Viridian Therapeutics Inc | 27.17 | -27.91% |
| ABVC | ABVC BioPharma Inc | 27.42 | -27.25% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | 27.49 | -27.07% |
| NTLA | Intellia Therapeutics Inc | 27.98 | -25.77% |
| INSM | Insmed Inc | 28.14 | -25.34% |
| RYTM | Rhythm Pharmaceuticals Inc | 28.92 | -23.27% |
| DARE | Dare Bioscience Inc | 29.12 | -22.74% |
| IRD | Ocuphire Pharma Inc | 29.62 | -21.41% |
| RNXT | RenovoRx Inc | 29.95 | -20.54% |
| BRTX | BioRestorative Therapies Inc | 30.66 | -18.66% |
| VTGN | VistaGen Therapeutics Inc | 31.24 | -17.12% |
| CBUS | Cibus Global Ltd. Class A | 32.04 | -14.99% |
| WHWK | Whitehawk Therapeutics Inc | 33.08 | -12.23% |
| ADAG | Adagene Inc | 33.94 | -9.95% |
| MESO | Mesoblast Ltd | 34.34 | -8.89% |
| MTNB | Matinas Biopharma Holdings Inc | 34.81 | -7.64% |
| OCUL | Ocular Therapeutix Inc | 35.93 | -4.67% |
| GLUE | Monte Rosa Therapeutics Inc | 38.14 | +1.19% |
| NKTR | Nektar Therapeutics | 39.40 | +4.53% |
| RANI | Rani Therapeutics Holdings Inc Class A | 41.28 | +9.52% |
| LEXX | Lexaria Bioscience Corp | 41.77 | +10.82% |
| IMTX | Immatics N.V | 41.96 | +11.32% |
| KTTA | Pasithea Therapeutics Corp | 42.15 | +11.83% |
| TOVX | Theriva Biologics Inc | 43.41 | +15.17% |
| XFOR | X4 Pharmaceuticals Inc | 45.10 | +19.66% |
| BYSI | BeyondSpring Inc | 45.99 | +22.02% |
| TRDA | Entrada Therapeutics Inc | 46.14 | +22.41% |
| PHIO | Phio Pharmaceuticals Corp | 48.01 | +27.38% |
| ADXN | Addex Therapeutics Ltd | 48.66 | +29.10% |
| PGEN | Precigen Inc | 48.97 | +29.92% |
| SPRB | Spruce Biosciences Inc | 49.19 | +30.51% |
| CBIO | Crescent Biopharma Inc | 49.82 | +32.18% |
| VYNE | VYNE Therapeutics Inc | 50.10 | +32.92% |
| KRRO | Korro Bio Inc | 50.34 | +33.56% |
| TNGX | Tango Therapeutics Inc | 50.76 | +34.67% |
| CLDI | Calidi Biotherapeutics Inc | 50.83 | +34.86% |
| HYPD | Eyenovia Inc | 50.86 | +34.94% |
| PPBT | Purple Biotech Ltd | 51.90 | +37.69% |
| FATE | Fate Therapeutics Inc | 52.41 | +39.05% |
| SGMT | Sagimet Biosciences Inc - Class A | 52.50 | +39.29% |
| KZIA | Kazia Therapeutics Ltd | 53.44 | +41.78% |
| ARMP | Armata Pharmaceuticals Inc | 57.66 | +52.98% |
| CAMP | CAMP4 Therapeutics Corp | 57.94 | +53.72% |
| ONCY | Oncolytics Biotech Inc | 58.60 | +55.47% |
| IBRX | ImmunityBio Inc | 58.62 | +55.53% |
| PRTC | PureTech Health plc American Depositary Shares | 59.84 | +58.76% |
| STOK | Stoke Therapeutics Inc | 60.01 | +59.21% |
| GLMD | Galmed Pharmaceuticals Ltd | 61.38 | +62.85% |
| NBTX | Nanobiotix | 62.88 | +66.83% |
| MCRB | Seres Therapeutics Inc | 65.35 | +73.38% |
| JANX | Janux Therapeutics Inc | 65.46 | +73.67% |
| OVID | Ovid Therapeutics Inc | 65.78 | +74.52% |
| EPIX | Essa Pharma Inc | 65.79 | +74.54% |
| DMAC | DiaMedica Therapeutics Inc | 66.68 | +76.91% |
| COCP | Cocrystal Pharma Inc | 68.63 | +82.08% |
| NRXP | NRX Pharmaceuticals Inc | 70.15 | +86.12% |
| MAZE | Maze Therapeutics Inc | 73.22 | +94.26% |
| IVA | Inventiva | 73.66 | +95.43% |
| ACRS | Aclaris Therapeutics Inc | 77.12 | +104.61% |
| ACIU | AC Immune SA | 78.63 | +108.61% |
| OMER | Omeros Corporation | 80.77 | +114.29% |
| ALLR | Allarity Therapeutics Inc | 83.03 | +120.29% |
| IMA | Ikena Oncology Inc | 83.32 | +121.06% |
| EVMN | Evommune Inc | 84.03 | +122.94% |
| ORMP | Oramed Pharmaceuticals Inc | 86.55 | +129.63% |
| QURE | uniQure N.V. | 87.74 | +132.78% |
| PTGX | Protagonist Therapeutics Inc | 88.77 | +135.52% |
| OGEN | Oragenics Inc | 89.28 | +136.87% |
| RLYB | Rallybio Corp | 89.66 | +137.88% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | 91.86 | +143.72% |
| APRE | Aprea Therapeutics Inc | 91.98 | +144.03% |
| CVM | Cel-Sci Corp | 92.88 | +146.42% |
| ADVM | Adverum Biotechnologies Inc | 94.37 | +150.37% |
| RAPP | Rapport Therapeutics Inc | 94.46 | +150.61% |
| SILO | SILO Pharma Inc | 96.56 | +156.19% |
| AEON | AEON Biopharma Inc - Class A | 97.16 | +157.78% |
| CYTK | Cytokinetics Inc | 98.99 | +162.63% |
| OCGN | Ocugen Inc | 104.63 | +177.60% |
| HIND | ReShape Lifesciences Inc | 107.54 | +185.32% |
| MNOV | Medicinova Inc | 109.72 | +191.10% |
| MREO | Mereo Biopharma Group Plc | 109.82 | +191.37% |
| RNAC | Cartesian Therapeutics Inc | 114.22 | +203.04% |
| MIST | Milestone Pharmaceuticals Inc | 114.35 | +203.38% |
| SKYE | Skye Bioscience Inc | 117.90 | +212.80% |
| ZBIO | Zenas Biopharma Inc | 119.50 | +217.05% |
| CAPR | Capricor Therapeutics Inc | 124.43 | +230.13% |
| KYMR | Kymera Therapeutics Inc | 130.11 | +245.20% |
| UPB | Upstream Bio Inc | 136.30 | +261.62% |
| HUMA | Humacyte Inc | 140.96 | +273.98% |
| EYPT | EyePoint Pharmaceuticals Inc | 149.54 | +296.75% |
| OPT | Opthea Ltd | 151.40 | +301.67% |
| MOLN | Molecular Partners AG | 156.56 | +315.37% |
| PRME | Prime Medicine Inc | 158.95 | +321.71% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | 169.88 | +350.71% |
| LSTA | Lisata Therapeutics Inc | 174.09 | +361.88% |
| NAMS | NewAmsterdam Pharma Company NV | 174.49 | +362.94% |
| GRDX | Entero Therapeutics Inc | 174.79 | +363.74% |
| DBVT | DBV Technologies | 190.89 | +406.45% |
| GRCE | Acasti Pharma Inc | 197.75 | +424.65% |
| GTBP | GT Biopharma Inc | 204.96 | +443.78% |
| ASBP | Aspire Biopharma Holdings Inc | 205.78 | +445.96% |
| CRNX | Crinetics Pharmaceuticals Inc | 207.45 | +450.39% |
| SER | AgeX Therapeutics Inc | 212.27 | +463.18% |
| TSHA | Taysha Gene Therapies Inc | 225.78 | +499.02% |
| CRDF | Cardiff Oncology Inc | 239.62 | +535.74% |
| AZTR | Azitra Inc | 239.97 | +536.67% |
| GANX | Gain Therapeutics Inc | 255.50 | +577.87% |
| CMPX | Compass Therapeutics Inc | 269.28 | +614.43% |
| CYBN | Cybin Inc | 278.25 | +638.23% |
| ATYR | Atyr Pharma Inc | 279.96 | +642.77% |
| RLAY | Relay Therapeutics Inc | 286.82 | +660.97% |
| IBIO | iBio Inc | 311.32 | +725.97% |
| OTLK | Outlook Therapeutics Inc | 325.59 | +763.83% |
| ALMS | Alumis Inc | 327.76 | +769.59% |
| CDIO | Cardio Diagnostics Holdings Inc | 337.66 | +795.85% |
| CLRB | Cellectar Biosciences Inc | 348.47 | +824.53% |
| VRNA | Verona Pharma Plc | 350.73 | +830.53% |
| ANIX | Anixa Biosciences Inc | 377.78 | +902.30% |
| SLN | Silence Therapeutics Plc | 386.21 | +924.66% |
| CNTA | Centessa Pharmaceuticals plc | 409.21 | +985.68% |
| ATNM | Actinium Pharmaceuticals Inc | 411.36 | +991.39% |
| TENX | Tenax Therapeutics Inc | 414.72 | +1000.30% |
| CADL | Candel Therapeutics Inc | 436.42 | +1057.87% |
| NGNE | Neoleukin Therapeutics Inc | 438.73 | +1064.00% |
| STTK | Shattuck Labs Inc | 455.87 | +1109.48% |
| AUTL | Autolus Therapeutics plc | 461.46 | +1124.31% |
| ATAI | ATAI Life Sciences N.V. | 465.49 | +1135.00% |
| LXEO | Lexeo Therapeutics Inc | 478.26 | +1168.88% |
| YDES | YD Bio Ltd | 487.14 | +1192.44% |
| JUNS | Jupiter Neurosciences Inc | 510.03 | +1253.17% |
| ABSI | Absci Corp | 516.29 | +1269.78% |
| ABOS | Acumen Pharmaceuticals Inc | 538.78 | +1329.45% |
| TVRD | Cara Therapeutics Inc | 559.61 | +1384.71% |
| IMRX | Immuneering Corp Class A | 563.62 | +1395.35% |
| IMNM | Immunome Inc | 635.78 | +1586.80% |
| CNTB | Connect Biopharma Holdings Ltd | 643.15 | +1606.35% |
| SYRE | Spyre Therapeutics Inc | 650.22 | +1625.11% |
| LNAI | Lunai Bioworks Inc | 666.81 | +1669.13% |
| XENE | Xenon Pharmaceuticals Inc | 727.44 | +1829.98% |
| GRCL | Gracell Biotechnologies Inc | 732.21 | +1842.64% |
| INMB | INmune Bio Inc | 760.34 | +1917.27% |
| TNYA | Tenaya Therapeutics Inc | 770.49 | +1944.20% |
| SNTI | Senti Biosciences Inc | 779.93 | +1969.25% |
| VRAX | Virax Biolabs Group Ltd - Class A | 793.06 | +2004.08% |
| COGT | Cogent Biosciences Inc | 861.15 | +2184.73% |
| PROK | ProKidney Corp - Class A | 876.39 | +2225.17% |
| PRAX | Praxis Precision Medicines Inc | 953.14 | +2428.79% |
| CGON | Cg Oncology Inc | 1083.44 | +2774.49% |
| OCS | Oculis Holding AG | 1143.55 | +2933.97% |
| INBX | Inhibrx Biosciences Inc | 1173.47 | +3013.35% |
| CRSP | CRISPR Therapeutics AG | 1263.03 | +3250.97% |
| ERNA | Ernexa Therapeutics Inc | 1275.37 | +3283.71% |
| PCSA | Processa Pharmaceuticals Inc | 1320.06 | +3402.28% |
| IBO | NYSE AMEX LISTED TEST STOCK FOR CTS CQS | 1437.62 | +3714.18% |
| TTNP | Titan Pharmaceuticals Inc (de) | 1459.05 | +3771.03% |
| ENTX | Entera Bio Ltd | 1547.08 | +4004.59% |
| INO | Inovio Pharmaceuticals Inc | 1712.37 | +4443.12% |
| ATOS | Atossa Therapeutics Inc | 1872.06 | +4866.80% |
| ABVX | Abivax | 2148.35 | +5599.83% |
| MBIO | Mustang Bio Inc | 2205.73 | +5752.06% |
| TCRT | Alaunos Therapeutics Inc | 2421.79 | +6325.30% |
| PULM | Pulmatrix Inc | 2459.21 | +6424.58% |
| ROIV | Roivant Sciences Ltd | 2601.91 | +6803.18% |
| BNTC | Benitec Biopharma Inc | 2770.13 | +7249.48% |
| CELZ | Creative Medical Technology Holdings Inc | 2809.47 | +7353.86% |
| CLDX | Celldex Therapeutics Inc | 2852.03 | +7466.77% |
| PLRX | Pliant Therapeutics Inc | 3071.82 | +8049.90% |
| NTHI | NeOnc Technologies Holdings Inc | 3477.63 | +9126.56% |
| KYTX | Kyverna Therapeutics Inc | 3513.34 | +9221.31% |
| CMRX | Chimerix Inc | 3613.35 | +9486.64% |
| DNLI | Denali Therapeutics Inc | 3643.65 | +9567.03% |
| DNTH | Dianthus Therapeutics Inc | 3805.77 | +9997.16% |
| SMMT | Summit Therapeutics Inc | 3891.31 | +10224.11% |
| PMN | ProMIS Neurosciences Inc | 4016.22 | +10555.51% |
| ALXO | Alx Oncology Holdings Inc | 5085.96 | +13393.65% |
| IFRX | InflaRx N.V. | 6161.81 | +16248.01% |
| GUTS | Fractyl Health Inc | 7575.74 | +19999.34% |
| ALLO | Allogene Therapeutics Inc | 7784.36 | +20552.83% |
| LPTX | Leap Therapeutics Inc | 8475.88 | +22387.51% |
| RLMD | Relmada Therapeutics Inc | 9001.90 | +23783.11% |
| RVMD | Revolution Medicines Inc | 9035.10 | +23871.19% |
| AVTX | Avalo Therapeutics Inc | 9875.25 | +26100.21% |
| ALT | Altimmune Inc | 10694.01 | +28272.47% |
| LYEL | Lyell Immunopharma Inc | 12668.15 | +33510.10% |
| PMCB | PharmaCyte Biotech Inc | 12904.41 | +34136.93% |
| GNLX | Genelux Corp | 17095.41 | +45256.15% |
| VTVT | vTv Therapeutics Inc - Class A | 17944.71 | +47509.44% |
| DSGN | Design Therapeutics Inc | 29402.82 | +77909.16% |
| TRML | Tourmaline Bio Inc | 30893.12 | +81863.11% |
| TIL | Instil Bio Inc | 54248.82 | +143828.54% |
| ETNB | 89bio Inc | 111568.68 | +295904.91% |
| EDSA | Edesa Biotech Inc | 130462.29 | +346031.90% |
| SVRA | Savara Inc | 145272.62 | +385325.46% |
| AKTX | Akari Therapeutics Plc | 478368.50 | +1269068.27% |
| NKTX | Nkarta Inc | 1.00M | +2653018.41% |